Journal article icon

Journal article

Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults

Abstract:
Background: Global WHO data indicate that Sub-Saharan African (SSA) countries, such as Kenya, experienced reduced coronavirus disease 2019 (COVID-19) severe-morbidity and mortality burdens relative to their more affluent counterparts in Europe, Asia, and North America. Methods: We analysed peripheral blood mononuclear cells (PBMC) samples collected from Kenya and Sweden before and during COVID-19. Pre-COVID-19 samples were available for 80 adults and 10 infants from Kenya, and 20 adults from Sweden. COVID-19 samples were available for 39 Kenyan adults. The samples were analysed for ex vivo IFN-γ secretion using an Enzyme-Linked Immunosorbent (ELISpot) assay following in vitro stimulations with overlapping SARS-CoV-2 spike-protein peptides. T-cells expressing IFN-γ, IL-2, TNF-α, CD154, and CD107a were assessed following similar stimulations, using intracellular cytokine staining (ICS) and multiparameter flow cytometry. Results: 55.7% of the Kenyan pre-COVID-19 adult samples were classified as responders by ELISPOT responses to spike-protein peptides, compared with 28% of Swedish pre-COVID-19 adult sample (p = 0.04). The frequencies for SARS-CoV-2 spike-specific TNF-α CD4+, TNF-α CD8 + and IFN-γ CD8 + T-cell responses, tended to be higher in the Kenyan adults although these differences did not reach statistical significance. Conclusion: Pre-COVID-19 T-cell responses could contribute to lower morbidity and mortality associated with SARS-CoV-2 infections in SSA relative to Europe, Asia, and North America.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Authors


More from this funder
Funder identifier:
https://ror.org/0456r8d26
More from this funder
Funder identifier:
https://ror.org/029chgv08
More from this funder
Funder identifier:
https://ror.org/03zttf063


Publisher:
BioMed Central
Journal:
BMC Infectious Diseases More from this journal
Volume:
26
Issue:
1
Article number:
174
Publication date:
2026-01-17
Acceptance date:
2026-01-09
DOI:
EISSN:
1471-2334
ISSN:
1471-2334


Language:
English
Keywords:
Pubs id:
2361670
UUID:
uuid_bd057aa0-1b5a-4dc7-93e8-6bbed3ee4da3
Local pid:
pubs:2361670
Source identifiers:
3699683
Deposit date:
2026-01-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP